Medical device startup NeuroWave Systems Inc. has reached a deal in which CareFusion (NYSE: CFN) will distribute NeuroWave's brain-activity monitoring system in Germany and Scandinavia. It's an important step for Cleveland Heights, Ohio-based NeuroWave, which in June received European regulatory clearance to begin selling its NeuroSense brain monitor for assessing anesthesia levels.
Medical device startup NeuroWave Systems Inc. has received regulatory clearance from the Food and Drug Administration to begin selling a brain-activity monitoring system. The Cleveland Heights, Ohio-based company's NeuroFAST Monitoring System is intended for use in hospital operating rooms, emergency departments and intensive care units with patients who've experienced some sort of brain trauma, such as seizures.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Medical device startup NeuroWave Systems Inc. has received the CE marking for its NeuroSense anesthesia monitor, enabling the company to sell its first product in Europe. The Cleveland Heights, Ohio company has been developing its brain-monitoring device since 2003 when it licensed the technology from co-inventor and now NeuroWave president, Tatjana Zikov. “This is a […]